Short Interest & Thesis
Short Interest & Thesis
Short interest is not decision-useful for ECLERX. India does not publish security-level aggregate short interest, so there is no official figure to anchor a positioning view. No credible short-seller report, activist short campaign, or accounting allegation specific to eClerx has surfaced in prior research, and forensic work returned a "Watch" verdict (22/100) with no red flags. The actionable insight is the inverse: with promoters at 54.5%, domestic institutions ~25% and FIIs ~10% of a ₹12,706 crore market cap, the float is structurally hard-to-short — a 20-day ADV of ~20,900 shares (~₹3.13 crore) means even a small short position would be unwindable only over many sessions.
Why "official short interest" doesn't exist for this name
eClerx trades only on Indian exchanges (NSE primary, BSE secondary). The Indian framework treats security-level outstanding short positions differently from the US/UK regimes that institutional analysts are used to seeing.
The data pipeline confirms this: zero reported short-interest rows, zero short-sale volume rows, zero public net-short disclosures, zero borrow-pressure rows, and zero peer-context rows were staged for ECLERX. This is a structural feature of the market, not a data-collection gap.
Inferred short capacity — what the float will actually allow
In the absence of reported short interest, the relevant question is whether anyone could run a meaningful short here. Three constraints — float composition, lendable supply, and ADV — say no.
The promoter block (Mundhra and Malik, 54.53%) is locked: no founder selling in 26 years, promoter pledge 0.00% every quarter since Dec 2023, and the promoter percentage has risen through non-participation in buybacks. That stake is functionally non-lendable. Domestic mutual funds hold ~26% (HDFC AMC alone 8.4%) — Indian mutual-fund stock-lending is permitted but is a small, opaque channel. FIIs hold ~10% and are the most plausible source of lendable supply, though there is no public security-level borrow data to size it.
The ADV constraint sharpens the picture further. Over the last 20 sessions ECLERX averaged 20,902 shares per day (₹3.13 crore in value); over 60 sessions it averaged 18,607 shares (₹2.87 crore). ADV/market cap is ~0.025% — the technicals page explicitly calls liquidity, not conviction, the binding constraint.
ADV 20d (shares)
ADV 20d (₹ cr)
ADV 60d (shares)
ADV 60d (₹ cr)
ADV / Market Cap
The point is asymmetric: any meaningful short position would (a) need to find lendable inventory from a thin pool, and (b) face many sessions of ADV exposure to cover. This is not a name where a US-style crowded-short setup can build silently.
Public short-thesis evidence — what's there, what isn't
There is no public credible short-thesis ledger for ECLERX. Prior forensic research explicitly searched for short-seller reports, fraud allegations, and activist short campaigns against eClerx across general-web, Reuters, Fool, and CNBC scopes; the only "short-seller" hits were generic Motley Fool commentary about Luckin Coffee, not eClerx.
The two items a thoughtful skeptic might still build a thesis around are the forensic yellow flags: the FY25 step-up in unbilled receivables (from ₹207 Cr to ₹294 Cr, 7.1% → 8.7% of revenue) and the Rule 11(g) audit-trail gaps across four accounting systems for most of FY25. Neither rises to a published short thesis today; both are watch-items rather than allegations.
Variant read for the skeptical PM: if FY26 standalone unbilled receivables stay at or above 8% of revenue, the forensic grade migrates from Watch to Elevated, and the unbilled trend becomes the most credible building block for a short narrative. The corollary: a snap-back toward 5–6% would close that door entirely.
Borrow & locate evidence — unavailable
No public security-level borrow cost, utilization rate, lendable-supply, rebate-rate, or hard-to-borrow indicator is available for ECLERX. The NSE SLB segment publishes outstanding positions at segment level only; broker-internal locate desks do not publish a public hard-to-borrow list comparable to the US tape. The pipeline staged zero borrow-pressure rows, consistent with this.
What can be inferred without official data: given (a) a 54.5% locked promoter block, (b) the absence of single-stock futures on the NSE F&O list, and (c) ADV that clears under ₹3.2 crore per day, locate friction would be the binding constraint on any sized short attempt, not borrow cost. This is an inference, not a measured rate.
Tape signals — squeeze and de-risking footprints
In the absence of position data, the only positioning signal available is the tape itself. The technicals work flagged one squeeze-like session on the way up, but the broader picture is unwind, not crowding.
The August 2025 +9% session is the only episode in the recent history that looks like a squeeze pattern (gap higher on outsized volume after a downtrend leg). Read alongside the structural locate friction, it is more parsimoniously explained as forced-buyer mechanics from an illiquid float than as evidence of a covered short book. The post-February 2026 decline is dominated by post-bonus de-rating and high realised vol — the conventional read is long-side de-risking, not short-side accumulation.
Peer / sector context
No public peer-level short-interest comparison is possible because peer Indian IT-services and BPM names face the same regime. US-listed peers (Genpact GENPACT, WNS Holdings WNS, ExlService EXLS, Concentrix CNXC) do report FINRA short interest, but those are not a clean peer-context for ECLERX — they are listed in a different regime, with different float profiles, different index inclusion, and different borrow mechanics. Citing their short-interest figures alongside ECLERX would imply a comparability that does not exist.
Evidence quality and limitations
Do not substitute proxies for the missing data. Daily aggregate institutional short-sale volume is not security-level short interest. A US-listed BPO peer's FINRA short interest is not a peer comparison for ECLERX. The honest institutional answer is that positioning data is structurally unavailable here, and the investment case should not lean on a short-interest signal that does not exist.
Bottom line for the PM
The short-interest lens does not change the ECLERX investment case in either direction. There is no measurable crowded-short, no public credible short thesis, no borrow-pressure signal, and the float is structurally hard-to-short. The only forensic items worth keeping in view are the FY25 unbilled-revenue step-up and the Rule 11(g) audit-trail gap — neither has been weaponised by a short-seller, but both are the most plausible building blocks if one ever is. Sizing and entry should be driven by the liquidity and trend work on the technicals page, not by an inferred positioning view.